Curevac kicks off new research on cancer

Frankfurt Tübingen-based Curevac AG has lagged far behind in cancer research in recent years, as has vaccines. But here, too, the biotechnology company has now embarked on a new endeavor: “Oncology is the area we will be targeting in parallel with vaccines for infectious diseases,” said Franz-Werner Haas, head of the company, in an interview … Read more